1887
Research Open Access
Like 0

Abstract

Introduction

SARS-CoV-2, the virus that causes COVID-19, has spread rapidly worldwide. In January 2020, a surveillance system was implemented in France for early detection of cases and their contacts to help limit secondary transmissions.

Aim

To use contact-tracing data collected during the initial phase of the COVID-19 pandemic to better characterise SARS-CoV-2 transmission.

Methods

We analysed data collected during contact tracing and retrospective epidemiological investigations in France from 24 January to 30 March 2020. We assessed the secondary clinical attack rate and characterised the risk of a contact becoming a case. We described chains of transmission and estimated key parameters of spread.

Results

During the study period, 6,082 contacts of 735 confirmed cases were traced. The overall secondary clinical attack rate was 4.1% (95% confidence interval (CI): 3.6–4.6), increasing with age of index case and contact. Compared with co-workers/friends, family contacts were at higher risk of becoming cases (adjusted odds ratio (AOR): 2.1, 95% CI: 1.4–3.0) and nosocomial contacts were at lower risk (AOR: 0.3, 95% CI: 0.1–0.7). Of 328 infector/infectee pairs, 49% were family members. The distribution of secondary cases was highly over-dispersed: 80% of secondary cases were caused by 10% of cases. The mean serial interval was 5.1 days (interquartile range (IQR): 2–8 days) in contact tracing pairs, where late transmission events may be censored, and 6.8 (3–8) days in pairs investigated retrospectively.

Conclusion

This study increases knowledge of SARS-CoV-2 transmission, including the importance of superspreading events during the onset of the pandemic.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.6.2001953
2022-02-10
2022-07-01
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.6.2001953
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/6/eurosurv-27-6-4.html?itemId=/content/10.2807/1560-7917.ES.2022.27.6.2001953&mimeType=html&fmt=ahah

References

  1. AFP-Agence France Presse. Coronavirus: 4.5 Billion People Confined. Barron's: New Jersey; 17 Apr 2020. Available from: https://www.barrons.com/news/coronavirus-4-5-billion-people-confined-01587139808
  2. Santé publique France. COVID-19 - Point épidémiologique hebdomadaire du 13 mai 2021. [COVID-19 weekly epidemiological report]. Saint-Maurice: Santé publique France. 13 May 2021. French. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-13-mai-2021
  3. Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020;25(6):2000094.  https://doi.org/10.2807/1560-7917.ES.2020.25.6.2000094  PMID: 32070465 
  4. Glasser JW, Hupert N, McCauley MM, Hatchett R. Modeling and public health emergency responses: lessons from SARS. Epidemics. 2011;3(1):32-7.  https://doi.org/10.1016/j.epidem.2011.01.001  PMID: 21420657 
  5. Swanson KC, Altare C, Wesseh CS, Nyenswah T, Ahmed T, Eyal N, et al. Contact tracing performance during the Ebola epidemic in Liberia, 2014-2015. PLoS Negl Trop Dis. 2018;12(9):e0006762.  https://doi.org/10.1371/journal.pntd.0006762  PMID: 30208032 
  6. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911-9.  https://doi.org/10.1016/S1473-3099(20)30287-5  PMID: 32353347 
  7. Liu T, Liang W, Zhong H, He J, Chen Z, He G, et al. Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing. Emerg Microbes Infect. 2020;9(1):1546-53.  https://doi.org/10.1080/22221751.2020.1787799  PMID: 32608325 
  8. Jing Q-L, Liu M-J, Zhang Z-B, Fang L-Q, Yuan J, Zhang A-R, et al. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(10):1141-50.  https://doi.org/10.1016/S1473-3099(20)30471-0  PMID: 32562601 
  9. Luo L, Liu D, Liao X, Wu X, Jing Q, Zheng J, et al. Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China : A Prospective Cohort Study. Ann Intern Med. 2020;173(11):879-87.  https://doi.org/10.7326/M20-2671  PMID: 32790510 
  10. Cheng H-Y, Jian S-W, Liu D-P, Ng T-C, Huang W-T, Lin H-H, et al. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Intern Med. 2020 01;180(9):1156-63.
  11. Park YJ, Choe YJ, Park O, Park SY, Kim Y-M, Kim J, et al. Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020. Emerg Infect Dis. 2020;26(10):2465-8.  https://doi.org/10.3201/eid2610.201315  PMID: 32673193 
  12. Laxminarayan R, Wahl B, Dudala SR, Gopal K, Mohan B C, Neelima S, et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science. 2020;370(6517):691-7.  https://doi.org/10.1126/science.abd7672  PMID: 33154136 
  13. Adam DC, Wu P, Wong JY, Lau EHY, Tsang TK, Cauchemez S, et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med. 2020;26(11):1714-9.  https://doi.org/10.1038/s41591-020-1092-0  PMID: 32943787 
  14. European Centre for Disease Prevention and Control (ECDC). Public health management of persons having had contact with cases of novel coronavirus in the European Union. Stockholm: ECDC; Feb 2020. Available from:https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-public-health-management-contact-novel-coronavirus-cases-EU.pdf
  15. Fontanet A, Tondeur L, Madec Y, Grant R, Besombes C, Jolly N, et al. Cluster of COVID-19 in northern France: A retrospective closed cohort study. medRxiv. 1Jan2020;2020.04.18.20071134.
  16. Béraud G, Kazmercziak S, Beutels P, Levy-Bruhl D, Lenne X, Mielcarek N, et al. The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases. PLoS One. 2015;10(7):e0133203.  https://doi.org/10.1371/journal.pone.0133203  PMID: 26176549 
  17. World Health Organization (WHO). The First Few X (FFX) Cases and contact investigation protocol for 2019-novel coronavirus (2019-nCoV) infection. Geneva: WHO. 23 Feb 2020. Available from: https://www.who.int/publications/i/item/the-first-few-x-cases-and-contacts-(-ffx)-investigation-protocol-for-coronavirus-disease-2019-(-covid-19)-version-2.2
  18. R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2020. Available from: http://www.R-project.org/
  19. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25(10).  https://doi.org/10.2807/1560-7917.ES.2020.25.10.2000180  PMID: 32183930 
  20. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020;17(9):e1003346.  https://doi.org/10.1371/journal.pmed.1003346  PMID: 32960881 
  21. Kwok KO, Wong VWY, Wei WI, Wong SYS, Tang JW-T. Epidemiological characteristics of the first 53 laboratory-confirmed cases of COVID-19 epidemic in Hong Kong, 13 February 2020. Euro Surveill. 2020;25(16):2000155.  https://doi.org/10.2807/1560-7917.ES.2020.25.16.2000155  PMID: 32347198 
  22. Larosa E, Djuric O, Cassinadri M, Cilloni S, Bisaccia E, Vicentini M, et al. Secondary transmission of COVID-19 in preschool and school settings in northern Italy after their reopening in September 2020: a population-based study. Euro Surveill. 2020;25(49):2001911.  https://doi.org/10.2807/1560-7917.ES.2020.25.49.2001911  PMID: 33303065 
  23. Liu Y, Eggo RM, Kucharski AJ. Secondary attack rate and superspreading events for SARS-CoV-2. Lancet. 2020;395(10227):e47.  https://doi.org/10.1016/S0140-6736(20)30462-1  PMID: 32113505 
  24. Thompson HA, Mousa A, Dighe A, Fu H, Arnedo-Pena A, Barrett P, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021;73(3):e754-64.  https://doi.org/10.1093/cid/ciab100  PMID: 33560412 
  25. Grijalva CG, Rolfes MA, Zhu Y, McLean HQ, Hanson KE, Belongia EA, et al. Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1631-4. . Available from: https://www.cdc.gov/mmwr/volumes/69/wr/mm6944e1.htm https://doi.org/10.15585/mmwr.mm6944e1  PMID: 33151916 
  26. Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020 10;369(6500):208-11.
  27. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669-77.  https://doi.org/10.1016/S1473-3099(20)30243-7  PMID: 32240634 
  28. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020;174(9):882-9.  https://doi.org/10.1001/jamapediatrics.2020.1467  PMID: 32320004 
  29. Du Z, Xu X, Wu Y, Wang L, Cowling BJ, Meyers LA. Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerg Infect Dis. 2020;26(6):1341-3.  https://doi.org/10.3201/eid2606.200357  PMID: 32191173 
  30. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672-5.  https://doi.org/10.1038/s41591-020-0869-5  PMID: 32296168 
  31. Tindale LC, Stockdale JE, Coombe M, Garlock ES, Lau WYV, Saraswat M, et al. Evidence for transmission of COVID-19 prior to symptom onset. eLife. 2020;9:e57149.  https://doi.org/10.7554/eLife.57149  PMID: 32568070 
  32. Zhao S, Gao D, Zhuang Z, Chong MKC, Cai Y, Ran J, et al. Estimating the Serial Interval of the Novel Coronavirus Disease (COVID-19): A Statistical Analysis Using the Public Data in Hong Kong From January 16 to February 15, 2020. Front Phys. 17 Sep 2020.  https://doi.org/http://dx.doi.org/10.3389/fphy.2020.00347 
  33. Ganyani T, Kremer C, Chen D, Torneri A, Faes C, Wallinga J, et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill. 2020;25(17).  https://doi.org/10.2807/1560-7917.ES.2020.25.17.2000257  PMID: 32372755 
  34. Endo A, Abbott S, Kucharski AJ, Funk S, Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group. Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China. Wellcome Open Res. 2020;5:67.  https://doi.org/10.12688/wellcomeopenres.15842.3  PMID: 32685698 
  35. Tariq A, Lee Y, Roosa K, Blumberg S, Yan P, Ma S, et al. Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020. BMC Med. 2020 03;18(1):166.
  36. Lau MSY, Grenfell B, Thomas M, Bryan M, Nelson K, Lopman B. Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proc Natl Acad Sci U S A. 2020;117(36):22430-5.  https://doi.org/10.1073/pnas.2011802117 
/content/10.2807/1560-7917.ES.2022.27.6.2001953
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error